Penicillin Allergy
Conditions
Brief summary
To test the implementation of penicillin allergy de-labelling delivered by the responsible clinical teams and the antimicrobial stewardship teams across all medical, surgical and critical care specialities in a UK hospital using the developed toolkit and a validated penicillin allergy decision support tool.
Detailed description
Aim: To test implementation of the penicillin allergy de-labelling complex intervention in surgical, medical and critical care patient pathway. Objectives: * To use the Institute for Health Improvement (IHI) Model for Improvement methodology to implement the penicillin allergy de-labelling complex intervention in each setting (surgery, medicine, critical care) * To measure the number of patients meeting inclusion criteria (\>16 with a penA not prescribed first line antibiotics) who have had their penicillin allergy record assessed by the wider clinical teams and separately by the AMS team. * To measure the patient uptake of penicillin allergy record removal (i.e. the rate of patient declining de-label / DOC). To interview 10-15 patients and 10-15 healthcare workers to gain insight into the penicillin allergy de labelling process.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
All adult (\>16) patients admitted to hospital over the study period with a penicillin allergy record preventing first line antibiotic use.
Exclusion criteria
None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The proportion of patients admitted to adult medical, surgical and critical care specialities with a penicillin allergy record, where the allergy record is preventing first line antibiotic therapy, that are safely de-labelled. | 1 year |
Countries
United Kingdom